
Quarterly ResultAug 13, 2026, 07:10 AM
SBC Q2 Net Income $10.69M, EPS $0.10; Revenue $49.19M
AI Summary
SBC Medical Group Holdings Inc. reported a significant increase in net income and revenue for the second quarter ended June 30, 2026. Net income attributable to the company surged to $10.69 million, or $0.10 per diluted share, compared to $2.46 million, or $0.02 per diluted share, in the prior year. Total revenues for the quarter rose to $49.19 million from $43.36 million. For the six months, net cash provided by operating activities improved substantially to $31.74 million from a negative $6.41 million.
Key Highlights
- Q2 2026 net income attributable to SBC Medical Group Holdings Inc. was $10.69 million, up 334.9% YoY.
- Q2 2026 diluted EPS was $0.10, a 400% increase from $0.02 in Q2 2025.
- Total revenues for Q2 2026 increased by 13.45% to $49.19 million.
- Gross profit for Q2 2026 rose to $35.98 million from $30.01 million in Q2 2025.
- Net cash provided by operating activities for H1 2026 was $31.74 million, compared to $(6.41) million in H1 2025.
- Total assets increased to $406.66 million as of June 30, 2026, from $380.45 million at Dec 31, 2025.
- Cash and cash equivalents increased to $184.31 million as of June 30, 2026, from $163.77 million at Dec 31, 2025.
Price Impact
More from SBC